Stocks Set to Pop

Shares of Bristol-Myers(BMY Quote - Cramer on BMY - Stock Picks) rose after the Food and Drug Administration cleared a drug for rheumatoid arthritis. The intravenously administered drug, abatacept, will be sold under the name Orencia.

Elsewhere, Dynegy(DYN Quote - Cramer on DYN - Stock Picks) closed another chapter of its foray into energy trading by terminating a wholesale power contract with a power plant in Louisiana. The company will record a fourth-quarter charge of $360 million.

Sirius(SIRI Quote - Cramer on SIRI - Stock Picks) says it has already made good on its oft-stated pledge to end the year with 3 million subscribers. In a premarket release, the satellite radio provider also said it expects a "strong year-end."

« Previous Page

1 2

Next Page »